elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35050195-1F3A5176-BE48-4111-962D-46BFD4C5888C
Q35050195-1F3A5176-BE48-4111-962D-46BFD4C5888C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-1F3A5176-BE48-4111-962D-46BFD4C5888C
Anticancer activity of the type I insulin-like growth factor receptor antagonist, ganitumab, in combination with the death receptor 5 agonist, conatumumab.
P2888
Q35050195-1F3A5176-BE48-4111-962D-46BFD4C5888C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35050195-1F3A5176-BE48-4111-962D-46BFD4C5888C
rank
NormalRank
type
BestRank
Statement
P2888
s11523-014-0315-z